SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry

Author:

Yang Bo12,Jia Yuanyuan1,Meng Yumin3,Xue Ying1,Liu Kefang3,Li Yan3,Liu Shichao1,Li Xiaoxiong1,Cui Kaige1,Shang Lina1,Cheng Tianyou1ORCID,Zhang Zhichao1,Hou Yingxiang14,Yang Xiaozhu1,Yan Hong1,Duan Liqiang1,Tong Zhou13ORCID,Wu Changxin14,Liu Zhida1,Gao Shan1,Zhuo Shu5,Huang Weijin6,Gao George Fu13ORCID,Qi Jianxun3ORCID,Shang Guijun12

Affiliation:

1. Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China

2. Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan 030012, China

3. Chinese Academy of Sciences Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China

4. Institutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China

5. Signet Therapeutics Inc, Shenzhen 518000, China

6. Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing 102629, China

Abstract

Significance We here established the interaction between PDZ binding motif (PBM) at the C terminal of ACE2 and PDZ domain of sorting nexin 27 (SNX27) and solved the crystal structure of ACE2-PBM/SNX27-PDZ complex. Together with retromer complex, SNX27 was found to regulate the homeostasis of cell surface ACE2 under physiological conditions. When endocytic pathway was used during SARS-CoV-2 infection, SNX27-retromer sorts ACE2/SARS-CoV-2 complex at early endosome and prevents it from entering lysosome/late endosome, inhibiting the cell entry of the virus. These findings add substantially to the current understanding of the important role of cytosolic tail of ACE2 during the invasion of SARS-CoV-2, and it could be used as a new therapeutic target for drug development.

Funder

National Natural Science Foundation of China

Science and Technology Major Projects of Shanxi Province

The Strategic Priority Research Program of the Chinese Academy of Sciences

The National Key Research and Development Program of China

The National Natural Science Foundation of China

International Collaborative Research Project of Shanxi

The Key R&D Plan of Shanxi Province

The National Science Foundation for Young Scientists of Shanxi Province

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3